Clint Tanner Allen

25PUBLICATIONS

68CO-AUTHORS

Molecular targetsReproductionEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 13, 2026

Spatial cellular order underlies locally-confined mechanisms of immune resistance in oropharyngeal cancer.

|Jan 16, 2026

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP.

Simon R Best, Aaron D Friedman, Clark A Rosen

|Dec 12, 2025

Hypoxia-induced EGR1 remodels neutrophils to suppress antitumor immunity.

Tian-Gen Chang, Jay Friedman, Paul E Clavijo

|Oct 28, 2025

Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models.

Francesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian

|Sep 01, 2025

Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma.

Binbin Wang, Robert Saddawi-Konefka, Lauren M Clubb

|Jul 09, 2025

Should All Patients With Recurrent Respiratory Papillomatosis Be Vaccinated for HPV?

Jena Yun, Clint T Allen, Daniel Faden

Pageof 5

Frequent Collaborators

James L Gulley

Jeffrey Schlom

James W Hodge

Eytan Ruppin

Cem Sievers

Kellsye P Fabian

Maxwell Y Lee

Scott Norberg

Doreen S Ben-Zvi

Sanju Sinha

Frequent Collaborators

James L Gulley

Jeffrey Schlom

James W Hodge

Eytan Ruppin